Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia

NCT05941585 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Mitoxantrone hydrochloride liposome injection30mg/m2
DRUG: HomoharringtonineD1-D7(2mg/m2/day)
DRUG: Venetoclax (d4 100mg/day, d5200mg/day ,d6-d12 400mg/day)
DRUG: Cytarabine(standard-dose:d1-d7100mg/m2/day)
DRUG: Cytarabine(intermediate-dose:d1-d4100mg/m2/day, d5-d7 1g/m2)
DRUG: Mitoxantrone hydrochloride liposome injection24mg/m2

Sponsor

Institute of Hematology & Blood Diseases Hospital, China